Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.70 |
| ▸ | ALPI | P09923 | 1/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | XIAP | P98170 | 1/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.65 |
| ▸ | EGFR | P00533 | 1/20 | 0.65 |
| ▸ | LCK | P06239 | 1/20 | 0.65 |
| ▸ | FYN | P06241 | 1/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.65 |
| ▸ | HTR2A | P28223 | 1/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | TPH1 | P17752 | 1/20 | 0.59 |
| ▸ | GRB2 | P62993 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL10978805 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL11676395 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL11520027 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL10978820 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1580 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL20787 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL11520041 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1581 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL11676367 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL30081492 | 1.00 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120264825-A1 | Amino Acid Perhydrates, Process for Their Preparation and Uses thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2012-10-18 | — | — | US | claimed |
| WO-2010128514-A1 | AMINO ACID PERHYDRATES, PROCESS FOR THEIR PREPARATION AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD (IL) | 2010-11-11 | — | — | WO | claimed |
| CN-108478852-A | A kind of pharmaceutical products, the carrier for loading pharmaceutical products, hydrogel and its method | 湖北工程学院 | 2018-09-04 | — | — | CN | disclosed |
| EP-2306192-B1 | Risk Markers For Cardiovascular Disease | CLEVELAND CLINIC FOUNDATION (US) | 2015-10-14 | — | — | EP | disclosed |
| US-9005904-B2 | Risk markers for cardiovascular disease | THE CLEVELAND CLINIC FOUNDATION (US) | 2015-04-14 | — | — | US | disclosed |
| US-20150037905-A1 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2015-02-05 | — | — | US | disclosed |
| US-8722344-B2 | Risk markers for cardiovascular disease | THE CLEVELAND CLINIC FOUNDATION (US) | 2014-05-13 | — | — | US | disclosed |
| US-20130177551-A1 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | HAZEN STANLEY L (US) | 2013-07-11 | — | — | US | disclosed |
| US-8338110-B2 | determining levels of one or more oxidized apolipoprotien A-I related biomolecules in a bodily sample; atherosclerosis | THE CLEVELAND CLINIC FOUNDATION (US) | 2012-12-25 | — | — | US | disclosed |
| US-20120264825-A1 | Amino Acid Perhydrates, Process for Their Preparation and Uses thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2012-10-18 | — | — | US | disclosed |
| EP-1697746-B1 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | CLEVELAND CLINIC FOUNDATION (US) | 2012-02-22 | — | — | EP | disclosed |
| EP-2306192-A2 | Risk Markers For Cardiovascular Disease | The Cleveland Clinic Foundation (US) | 2011-04-06 | — | — | EP | disclosed |
| WO-2010128514-A1 | AMINO ACID PERHYDRATES, PROCESS FOR THEIR PREPARATION AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD (IL) | 2010-11-11 | — | — | WO | disclosed |
| US-7781219-B2 | determining levels of one or more oxidized apolipoprotien A-I related biomolecules in a bodily sample; atherosclerosis | THE CLEVELAND CLINIC FOUNDATION (US) | 2010-08-24 | — | — | US | disclosed |
| US-20100183607-A1 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2010-07-22 | — | — | US | disclosed |
| EP-1697746-A4 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | CLEVELAND CLINIC FOUNDATION (US) | 2007-08-29 | — | — | EP | disclosed |
| EP-1697746-A2 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | The Cleveland Clinic Foundation (US) | 2006-09-06 | — | — | EP | disclosed |
| US-20050239136-A1 | Risk markers for cardiovacular disease | THE CLEVELAND CLINIC FOUNDATION | 2005-10-27 | — | — | US | disclosed |
| WO-2005055810-A2 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2005-06-23 | — | — | WO | disclosed |